Performance and Impact of the Sepsis ImmunoScore

Starting soon

Conditions studied: Sepsis

In brief

The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.

Key facts

Study ID

NCT07543497

Run by

Prenosis, Inc.

People needed

5000

Starts

2026-04-01

Expected to finish

2027-12-01

Last updated by the study team

2026-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (age 18 years or older) patients presenting to hospitals and emergency departments of medical institutions across the United States.
• Adult (age 18 years or older) patients suspected of sepsis.

You may not qualify if…

• none

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.